Mass General Brigham Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
7
- Investments
-
101
- Portfolio
-
28
- Exits
-
32
Mass General Brigham Ventures General Information
Company Description
Founded in 2008, Mass General Brigham Ventures is a corporate venture capital firm based in Somerville, Massachusetts. The firm seeks to invest in life science technologies, medical devices, drugs, therapeutics, diagnostics, and digital health sectors. The firm targets seed- and early-stage companies emerging from the Mass General Brigham research community. This firm is a Registered Investment Adviser (RIA).
Business Details
Year Founded
Investor Status
Primary Investor Type
Corporate Office
- 399 Revolution Drive
- Suite 999
- Somerville, MA 02145
- United States
Mass General Brigham Ventures Investments (101)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Oyster Therapeutics | 10-Nov-2026 | Later Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| Abcuro | 14-Aug-2026 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Altido Therapeutics | 01-Aug-2026 | Biotechnology | Pre-Clinical Trials | |||
| Crosstalk Bio | 01-Aug-2026 | Biotechnology | Startup | |||
| Falcon Bio | 01-Aug-2026 | Drug Discovery | Startup | |||
| Claris Bio | 24-Jul-2026 | Biotechnology | Clinical Trials - General | |||
| InStride Health | 15-Jun-2026 | Clinics/Outpatient Services | Generating Revenue | |||
| Violet Therapeutics | 17-Apr-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Nocion Therapeutics | 07-Jan-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Monimoi Therapeutics | 01-Jan-2026 | Early Stage VC | Drug Discovery | Startup |
Mass General Brigham Ventures Exits (32)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Stratus Therapeutics | 27-Jul-2026 | Out of Business | |
| Rippl Care | 13-Feb-2026 | ||
| ROME Therapeutics | 12-Jan-2026 | ||
| ZielBio | 03-Jul-2025 | ||
| Lyndra Therapeutics | 25-Mar-2025 | ||
| Scorpion Therapeutics | 01-Mar-2025 | ||
| SeQure DX | 29-Jan-2025 | ||
| Amolyt Pharma | 15-Jul-2024 | ||
| SwanBio Therapeutics | 25-Jun-2024 | Merger/Acquisition | |
| AKUOS | 01-May-2024 | Bankruptcy: Liquidation |
Mass General Brigham Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Mass General Brigham Ventures Co-Investors (161)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Mission BioCapital | 4 |
|
|
||
| Alexandria Venture Investments |
|
|
|||
| F-Prime |
|
|
|||
| GV |
|
|
|||
| General Catalyst |
|
|
Mass General Brigham Ventures FAQs
-
What is Mass General Brigham Ventures?
Founded in 2008, Mass General Brigham Ventures is a corporate venture capital firm based in Somerville, Massachusetts.
-
When was Mass General Brigham Ventures founded?
Mass General Brigham Ventures was founded in 2008.
-
Where is Mass General Brigham Ventures headquartered?
Mass General Brigham Ventures is headquartered in Somerville, MA.
-
What is Mass General Brigham Ventures's total asset value?
Mass General Brigham Ventures has around in total assets under management.
-
How many investments has Mass General Brigham Ventures made?
Mass General Brigham Ventures has made 101 investments.
-
What has Mass General Brigham Ventures invested in?
Mass General Brigham Ventures has made numerous investments in companies like Oyster Therapeutics, Abcuro, and Altido Therapeutics within the Drug Discovery and Biotechnology industries.
-
What has Mass General Brigham Ventures invested in recently?
Mass General Brigham Ventures's latest investment was on 10-Nov-2026 in Oyster Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
